Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.55
Delayed Data
As of 2:46pm ET
 -0.12 / -4.49%
Today’s Change
2.50
Today|||52-Week Range
7.50
-26.51%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Czirr James C
Executive Chairman
Sale1/31/201593,168$3.22$300.0K-17.08%
Czirr James C
Executive Chairman
Buy1/31/2015166,667$1.80$300.0K-17.08%
Traber Peter G
President & Chief Executive Officer
Buy6/01/20154,000$2.53$10.1K-0.74%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.48$9.0K-42.08%
Traber Peter G
President & Chief Executive Officer
Buy8/14/20142,000$4.44$8.9K-42.08%
Freeman Kevin D
Director
Buy6/01/20152,083$2.70$5.6K-0.74%
Freeman Kevin D
Director
Buy8/15/20141,000$4.70$4.7K-44.14%
Greenberg Arthur R
Director
Buy8/19/20141,000$4.56$4.6K-41.70%
Callicutt Jack W
Chief Financial Officer
Buy8/14/20141,000$4.55$4.6K-42.08%
Traber Peter G
President & Chief Executive Officer
Buy8/13/20141,000$4.42$4.4K-39.04%
Page of 4